CELL INTELLIGENCE · 肿瘤细胞治疗研究

2025 年儿童肿瘤学东部与地中海双年会议亮点：推动东地中海地区儿童肿瘤学发展

Highlights From the 2025 Pediatric Oncology East and Mediterranean Biennial Conference: Advancing Pediatric Oncology Across the Eastern Mediterranean.

2025 年 POEM 双年会议重申了该网络作为推动东地中海地区儿童癌症诊疗进步催化剂的角色。

基因治疗：改变对抗胰腺癌的战局

Gene Therapy: Transforming the Battle Against Pancreatic Cancer.

FDA 批准摘要：Afamitresgene Autoleucel 用于既往接受过化疗的 HLA 限制性、MAGE-A4 阳性不可切除或转移性滑膜肉瘤成人患者

FDA Approval Summary: Afamitresgene Autoleucel for Adults with HLA-Restricted, MAGE-A4-Positive Unresectable or Metastatic Synovial Sarcoma after Prio

骨肉瘤的系统性治疗策略：进展与未来方向

Systemic strategies for osteosarcoma: advances and future directions.

肉瘤的基因与细胞治疗：综述

Gene and Cell Therapy for Sarcomas: A Review.

携带诱导型 caspase-9 自杀基因的 FGFR4 特异性 CAR-T 细胞治疗横纹肌肉瘤的策略

FGFR4-specific CAR-T cells with inducible caspase-9 suicide gene as an approach to treat rhabdomyosarcoma.

骨肉瘤医学顾问委员会智库会议纪要

Proceedings of the Think Tank for Osteosarcoma Medical Advisory Board.

仿生纳米颗粒递送多柔比星与 siRNA 协同治疗骨肉瘤

Synergistic treatment of osteosarcoma with biomimetic nanoparticles transporting doxorubicin and siRNA.

DOX/siSUR-PLGA@MSCM NPs 基于其良好的肿瘤靶向性与生物安全性，通过化疗药物与基因治疗的联合，可在骨肉瘤患者中显示出更优的治疗效果。